Volume 10, Issue 2 ( June 2018 2018)                   Iranian Journal of Blood and Cancer 2018, 10(2): 35-38 | Back to browse issues page

XML Print


1- Department of Pharmaceutics, Faculty of Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran/ Iran
2- Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran/Iran , mpourmokhtar@gmail.com
Abstract:   (3816 Views)
Background: Despite the availability of a wide range of antibiotics, bacterial infections are among important challenges for the healthcare system. Therefore, the introduction of new antimicrobial preparations such as platelet-rich plasma (PRP) could be suggested theoretically as a preventive measure for bacterial infections. We aimed to evaluate the in vitro antibacterial activity of PRP against three common oral bacteria.
Methods: In vitro antibacterial activity of PRP against Streptococcus Mitis, Streptococcus Mutans, and Neisseria Lactamica as three common oral/dental bacteria was determined by disc diffusion method. Baseline antibacterial activity was assessed by measuring the diameter zone of inhibition after 24 hours of incubation at 37 °C.
Results: PRP had strong in vitro antibacterial activity against Streptococcus Mitis, Streptococcus Mutans and Neisseria Lactamica with the mean zone of inhibition diameters of 6.73±0.52, 5.8±0.43 and 6.67±0.43 mm, respectively.
Conclusion: PRP is an effective antibacterial agent along with conventional antibiotic treatments against oral and periodontal infections.
Full-Text [PDF 648 kb]   (2158 Downloads)    
: Original Article | Subject: Infectious Diseases
Received: 2018/02/28 | Accepted: 2018/04/21 | Published: 2018/08/26

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.